Did Ozempic Spoil Your Christmas Dinner?

Weight-loss injections such as Ozempic have altered festive meal preparations for many Brits. Recent studies show changes in buying habits and rising concerns among hosts. Health tracking tools can aid in monitoring these shifts.

Was your holiday meal noticeably lighter this season? Fewer roasted potatoes? Absent Brussels sprouts? Tiny Yorkshire puddings?

The reason might be GLP-1, commonly recognized as weight-loss injections like Ozempic or Mounjaro.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Recent information indicates that 60% of UK residents on weight-loss jabs modified their Christmas dinner shopping patterns prior to the holiday, opting for fewer groceries.

And it's not solely those on the injections affected; CheqUp's data demonstrates over half of British hosts for Christmas dinner experiencing worry regarding the appropriate portion sizes for their holiday meal. Health tracking apps like Shotlee can help monitor diet and weight loss progress.

Source Information

Originally published by LBC.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: weight loss

All weight loss articles →

Wellness & Health

New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It

New York City is experiencing a surge in peptide therapy requests via telehealth platforms. This article explores the most popular compounds, safety protocols, and how to track results effectively.

8 min read

More in Health

Health

New Year, New Scam: Fraudsters Target Dieters with Bogus Weight Loss Drugs

As weight loss becomes a popular New Year's resolution, many are turning to GLP-1 medications. However, scammers are leveraging fake websites and offers to steal money and personal data. The Better Business Bureau warns of fraudulent schemes targeting those seeking weight loss solutions.

2 min read

Health

Natural Alternatives to Ozempic? 6 GLP-1 Rich Foods That Mimic the Effects

Weight loss medications such as Ozempic and Wegovy function by artificially elevating glucagon-like peptide 1 (GLP-1), a naturally occurring hormone that combats obesity and diabetes. Research indicates that certain foods can boost GLP-1 secretion, offering similar benefits without injections. These foods not only increase GLP-1 but also mimic its effects, aiding in weight management and overall health.

6 min read

Health

Weight Loss Meds Linked to Another Debilitating Adverse Effect

Weight loss medications, specifically GLP-1 receptor agonists, have been associated with an increased risk of chronic cough in individuals with type 2 diabetes. A recent study compared patients taking GLP-1s with those on other diabetes treatments, revealing a notable link between the drugs and persistent coughing.

5 min read